Kaposi sarcoma in a patient treated with ruxolitinib

Ann Oncol. 2017 Jul 1;28(7):1670-1671. doi: 10.1093/annonc/mdx188.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Trials, Phase II as Topic
  • Humans
  • Male
  • Middle Aged
  • Nitriles
  • Pyrazoles / adverse effects*
  • Pyrazoles / therapeutic use
  • Pyrimidines
  • Sarcoma, Kaposi / chemically induced*
  • Sarcoma, Kaposi / pathology
  • Thrombocythemia, Essential / drug therapy*

Substances

  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib